Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron disease
Human Molecular Genetics · 11.05.2026 · 35 (8)
DOI: 10.1093/hmg/ddag034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 21.05.2026. Verfasst von Hiu Chuen Lok und 20 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, 2006 NSW, Australia. Hauptthemen laut MEDLINE: Frontotemporal Dementia, Motor Neuron Disease, Laminin. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health & Medical Research Council Project, Dementia Research Team, National Health & Medical Research Council Boosting Dementia Research Leadership Fellowship.
Themen: Demenz
Abstract (Originalsprache)
There is overlap between frontotemporal dementia (FTD) and motor neuron disease (MND) in terms of genetics, neuroimaging and clinical phenotypes. We aimed to identify in three patient cohorts, ultra-rare variants (frequency ≤ 0.00002) in genes whose mutations are associated with white matter dysfunction, and to examine impact of these variants on protein function in vitro, and neuroimaging and lipid profiles in vivo. Next generation sequencing (NGS) of N = 289 patients with clinical FTD recruited through two dementia research clinics identified ultra-rare variants in established leukodystrophy genes, including ARSA. Further, novel and ultra-rare loss-of-function and missense variants in LAMA2 increased risk of disease in three independent cohorts, including N = 598 MND and N = 14 logopenic variant primary progressive aphasia (lvPPA) patients (maximum odds ratio (OR) of 3.05, P = 0.0357 for FTD cohort, OR of 9.57, P = 0.0233 for lvPPA cohort, and 1.78, P = 0.0250 for MND cohort). An in vitro transfection assay demonstrated a loss-of-secretion phenotype in the subset of LAMA2 ultra-rare missense variants where the full-length proteins were translated but not secreted into growth media. LAMA2 ultra-rare variant carriers have a distinctive serum lipidomics profile compared with sporadic cases and cognitively normal controls. Finally, LAMA2 ultra-rare variants were associated with white matter changes in brain regions relevant to disease process. Our results broaden the phenotypes associated with LAMA2 from muscular dystrophies to include FTD, lvPPA and MND; and our data provide convergent evidence for the role of ultra-rare variants in LAMA2 as risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, 2006 NSW, Australia.
- Brain and Mind Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, 2006 NSW, Australia.
- School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, 2006 NSW, Australia.
- Charles Perkins Centre, The University of Sydney, Camperdown, 2006 NSW, Australia.
- Macquarie University Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, 2109 NSW, Australia.
- Centre for Healthy Brain Ageing, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, 2052 NSW, Australia.
ORCID-Profile: Karen A Mather, Wei Wen, Perminder S Sachdev, Olivier Piguet, Glenda M Halliday, Woojin S Kim, John B Kwok
Förderung
- National Health & Medical Research Council Project
- Dementia Research Team
- National Health & Medical Research Council Boosting Dementia Research Leadership Fellowship
- National Health & Medical Research Council Investigator
- MND Research Australia Beryl Bayley Postdoctoral Fellowship
- FightMND IMPACT
- National Health & Medical Research Council program
- Dementia Team
Zitieren
APA
Lok, H. C., Dobson-Stone, C., Hallupp, M., Matis, S., Landin-Romero, R., Guennewig, B., Mundell, H., Don, A. S., Fifita, J., McCann, E. P., Fat, S. C. M., Blair, I. P., Mather, K. A., Thalamuthu, A., Wen, W., Sachdev, P. S., Brooks, W. S., Piguet, O., Halliday, G. M., …, & Kwok, J. B. (2026). Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron disease. Human Molecular Genetics, 35(8). https://doi.org/10.1093/hmg/ddag034
Vancouver
Lok HC, Dobson-Stone C, Hallupp M, Matis S, Landin-Romero R, Guennewig B, et al. Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron disease. Human Molecular Genetics. 2026;35(8). doi:10.1093/hmg/ddag034
BibTeX
@article{Lok2026,
author = {Lok, Hiu Chuen and Dobson-Stone, Carol and Hallupp, Marianne and Matis, Sophie and Landin-Romero, Ramon and Guennewig, Boris and Mundell, Hamish and Don, Anthony S and Fifita, Jennifer and McCann, Emily P and Fat, Sandrine Chan Moi and Blair, Ian P and Mather, Karen A and Thalamuthu, Anbupalam and Wen, Wei and Sachdev, Perminder S and Brooks, William S and Piguet, Olivier and Halliday, Glenda M and Kim, Woojin S and Kwok, John B},
title = {Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron disease},
journal = {Human Molecular Genetics},
year = {2026},
volume = {35},
number = {8},
doi = {10.1093/hmg/ddag034}
}
EUVIMED